Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

/PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet...

Related Keywords

Stockholm ,Sweden ,Magnus Christensen ,Jens Lindberg , ,Nasdaq Stockholm ,Small Cap ,Medivir ,